These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the concept of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-connected disorders. This plant-based mostly component presents https://mauriced799plv5.wikiinside.com/user